#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Graft versus host disease Phenylketonuria Usher's syndrome Anal fistula Parkinson's disease Leber's congenital amaurosis Bladder cancer Acute graft versus host disease in intestine Pleomorphic leiomyosarcoma Blastic plasmacytoid dendritic cell neoplasia Pleomorphic liposarcoma Cardiac failure acute Breast cancer Hepatocellular carcinoma Stiff person syndrome More trials…

    Learn about Rare Diseases

    Congenital nephrogenic diabetes insipidus Hyperoxaluria Haemophilia A without inhibitors – Life with Disease Primary mediastinal large B-cell lymphoma Primary immunodeficiency syndrome – Life with Disease X-linked lymphoproliferative syndrome – Treatment Primary hyperoxaluria – Life with Disease Medulloblastoma recurrent – Trials in Disease Pleomorphic leiomyosarcoma – Trials in Disease Lymphatic malformation – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Regtivex Meropenem Anhydrous Bendamustine Leuprorelin Acetate Cefixime SODIUM SELENITE PENTAHYDRATE Cefiderocol Eltrombopag Davutamig Sirolimus Mva-209-Fsp-B1 Acetylcholine Chloride Fludrocortisone Bupivacaine Immunostimulants Cefixime Trihydrate Etoposide Varegacestat Keto-Valine Calcium Tadalafil More therapies…

    Learn about Your Condition

    Femoral neck fracture Salivary gland cancer Urticaria Liposarcoma recurrent Neuropathic arthropathy Glioblastoma Ehlers-Danlos syndrome Endometrial adenocarcinoma Eosinophilic gastritis Pancreatic carcinoma recurrent Medullary thyroid cancer Type 2 diabetes mellitus Acute promyelocytic leukaemia Hydrocele Carotid artery stenosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Alopecia areata

  • A Phase 2a Study of ly4005130 in Adults with Severe Alopecia Areata

    Recruiting

    2 1
    The Netherlands Poland

  • A study to evaluate the effectiveness and safety of LAD603 in adults with severe to very severe alopecia areata

    Recruiting

    2 1
    Investigated Diseases:
    • Alopecia areata
    Bulgaria Germany Poland Romania Spain

  • Long-term safety and effectiveness study of ritlecitinib in children with severe alopecia areata who completed previous trials B7981027 or B7981031

    Recruiting

    3 1
    Czechia France Italy Poland Spain

  • A study comparing how ritlecitinib capsules work when sprinkled on food versus swallowed whole and with or without food in healthy adults

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Vitiligo
    • Alopecia areata
    • Rheumatoid arthritis
    Belgium

  • Study of ritlecitinib for treating severe alopecia areata in children aged 6 to under 12 years

    Not recruiting

    3 1
    Czechia France Italy Poland Spain

  • Study on Etrasimod Arginine for Patients with Ulcerative Colitis, Alopecia Areata, Atopic Dermatitis, and Eosinophilic Esophagitis

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Eosinophilic oesophagitis
    • Alopecia areata
    • Colitis ulcerative
    Investigated Drugs:
    • Etrasimod Arginine
    Belgium
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!